Nexium, Prilosec Kidney Injury Lawyers Set to Meet with MDL Judge for Case Status Conference

As the organizational structure continues to be established for all Nexium casesPrilosec casesPrevacid cases and other claims brought in the federal court system against the makers of proton pump inhibitors (PPI) over kidney injuries, lawyers involved in the litigation are set to meet tomorrow with the U.S. District Judge presiding over all pretrial proceedings.

There are currently about 275 product liability lawsuits centralized in a federal multidistrict litigation (MDL), which was established for all claims involving kidney damage allegedly caused by the popular heartburn drugs. The cases have all been transferred to U.S. District Judge Claire C. Cecchi in the District of New Jersey to reduce duplicative discovery, avoid conflicting pretrial rulings and to serve the convenience of the parties, witnesses and the courts.

Each of the complaints raise similar allegations that makers of Nexium, Prilosec, Prevacid and other PPI drugs failed to adequately warn consumers and the medical community about the risk that users may develop a kidney injury, acute interstitial nephritis, chronic kidney disease or end-stage renal failure.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

According to a joint status report and agenda (PDF) filed in advance of a case management conference set for October 11, lawyers involved in the litigation intend to address a number of organizational and structural issues necessary to advance the litigation.

Judge Cecchi is expected to review the status of a direct filing order in the federal multidistrict litigation, which would allow lawyers to file additional cases directly into the MDL, and avoid the delays associating with transferring cases from U.S. District Courts nationwide.

Parties also indicate that they are conferring regarding product identification and injury diagnosis records, Plaintiff Fact Sheets, Defendant Fact Sheets and other orders regarding the schedule for pretrial discovery.

The timing and protocol for a potential “Science Day” will also likely be discussed, as such non-adversarial presentations are typically scheduled in complex pharmaceutical litigation to help educate the court on key issues that will arise in the cases.

Proton Pump Inhibitors include some of the most widely recognized brand name medications on the market in the United States, and millions of Americans have used Nexium, Prilosec and other similar heart burn drugs. Kidney injury lawyers expect that there may ultimately be several thousand complaints filed in the federal MDL in the coming months and years.

As part of the coordinated MDL proceedings, Judge Cecchi is likely to establish a “bellwether” program, where small groups of cases involving Nexium, Prilosec, Protonix and other PPI medications will go prepared for early trial dates, which are designed to help the parties gauge how juries may respond to certain evidence and testimony that may be repeated throughout the litigation. However, if the parties fail to negotiate settlements or another resolution, each of the individual cases may eventually be remanded back to various U.S. District Courts nationwide in the future for separate trial dates.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General
Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General (Posted today)

U.S. Surgeon General says social media platforms like Facebook, Instagram and Tiktok should carry label warnings, alerting parents that youth who use the platforms face an increased risk of mental health side effects.

Camp Lejeune Contaminated Water Lawsuits To Be Selected For Track 1 Bellwether Trials
Camp Lejeune Contaminated Water Lawsuits To Be Selected For Track 1 Bellwether Trials (Posted yesterday)

Lawyers will select 25 Camp Lejeune lawsuits involving kidney cancer, bladder cancer, leukemia, non-Hodgkin's lymphoma or Parkinson's disease from a group of 100 eligible cases, which will be prepared for a series of early test trials.